News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials
Guru Sonpavde/adventhealth.com
Oct 21, 2024, 19:19

Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials

Guru Sonpavde shared a post on LinkedIn:

”ESMO24 bladder cancer potentially practice-changing highlights from 2 key Phase III clinical trials on Doximity: Pleased to comment on NIAGARA (Neoadjuvant Gemcitabine-Cisplatin +/- peri-operative durvalumab for muscle-invasive bladder cancer) and AMBASSADOR (Adjuvant pembrolizumab vs observation for muscle-invasive bladder cancer) trials from AdventHealth Central Florida Cancer Institute, Orlando, Florida.”

Read further.

Adjuvant pembrolizumab AdventHealth Central Florida Cancer Institute bladder cancer cancer clinical trials Doximity Durvalumab ESMO24 Guru Sonpavde OncoDaily Oncology
Special Coverage
Drugs
Feb 25, 2025, 16:56
Tarlatamab (Imdelltra): What Patients Need to Know About
Science
Feb 25, 2025, 15:10
Wafaa M Rashed: Genomic Innovation for Economic Development
Drugs
Feb 25, 2025, 14:43
Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Feb 25, 2025, 14:12
5 articles suggested by Wafik El-Deiry
Blog
Feb 25, 2025, 14:04
M. Bilal Abid: Concluded the PANAO 2025 conference
Blog
Feb 25, 2025, 13:56
Jasmin Hundal: What Drives Cancer Risk in Adults vs. Children?
Blog
Feb 25, 2025, 13:46
Enrico Pozzo: I will join Humanitas Research Hospital in Milan as staff member
Career
Feb 25, 2025, 13:39
Patrizia Cavazzoni Rejoins Pfizer as Chief Medical Officer and Executive Vice President
Blog
Feb 25, 2025, 13:38
Sean Burroughs: 2025 Funding Rounds and Growing Therapeutic Trends
Blog
Feb 25, 2025, 13:28
Exploratory analysis of biomarkers and histology in DUO-E pMMR - Spanish Gynaecological Cancer Research Group
Science
Feb 25, 2025, 13:26
Partha Basu: 'Screen, triage and treat' vs 'screen and treat' for WLHIV positive on HPV test
Blog
Feb 25, 2025, 11:39
Applonia Rose: Exciting findings on prognostic scoring in metastatic renal cell carcinoma